-Introduction
Addiction is a chronic debilitating condition with a high rate of relapse, for which as yet there is no effective treatment (Kalivas and O'Brien, 2008; McLellan et al., 2000) . The mechanisms underlying the shift from controlled recreational use of drugs to pathological compulsive behavior are not yet fully understood, nor are the long-lasting neuroadaptive changes behind the elevated risk of relapse.
The development of an addiction depends on synaptic plasticity, which in turn relies on protein synthesis (Kalivas and O'Brien, 2008; Kauer and Malenka, 2007; Lüscher and Malenka, 2011) . Thus, a signaling pathway that has generated much interest of late is that involving the mechanistic target of rapamycin, mTOR, a serine/threonine kinase that plays an important role in different aspects of cell growth, proliferation and survival (Kwon et al., 2003; Pearce et al., 2010; Zhou et al., 2009 ). This protein nucleates two different multi-protein complexes known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). These complexes are part of a pathway which integrates many intracellular and extracellular signals, and regulates processes such as protein, lipid and nucleotide synthesis (Düvel et al., 2010; Ma and Blenis, 2004; Porstmann et al., 2008; Stoica et al., 2011) , autophagy (Blommaart et al., 1995) , mitochondrial metabolism (Cunningham et al., 2007; Schieke et al., 2006) and cytoskeletal organization (Sarbassov et al., 2004) . Given its role in protein synthesis-dependent synaptic plasticity (Casadio et al., 1999; Costa-Mattioli et al., 2009; Liu-Yesucevitz et al., 2011; Stoica et al., 2011) , this pathway is thought to participate in the neurobiology of addictions. Accordingly, several studies have focused on the effects of rapamycin, an inhibitor of mTOR activity, on addictive behavior.
These studies suggest that this signaling pathway is involved in the long-lasting neuroadaptations that occur as addictive disorders progress (Dayas et al., 2012; Neasta et al., 2014) . For example, rapamycin was able to reduce the rewarding effects of cocaine (Bailey et al., 2012; J Wu et al., 2011) and amphetamine (Narita et al., 2005) when measured in a conditioned place preference (CPP) test (Wang et al., 2010) . Systemic rapamycin injections also reduced motivation for self-administered cocaine in rats as measured in a progressive ratio schedule of reinforcement (James et al., 2016) . In addition, there was a reduction in cue induced reinstatement of cocaine seeking when rapamycin was injected directly in the core of the nucleus accumbens (NAcc) (Wang et al., 2010) and the Mtor gene expression was down-regulated in the ventral striatum of relapse-prone rats (Brown et al., 2011) . Rapamycin also blocked nicotine-induced behavioral sensitization and activation by effectors of mTORC1. It has also been suggested that the dopamine receptor 1/mTOR complex 1-dependent plasticity is recruited following a first alcohol exposure and that it may be a critical cellular component of reinforcement learning (Beckley et al., 2016) . In terms of opiates, chronic morphine decreases the soma size of dopaminergic cells in the ventral tegmental area (VTA), and neurotransmitter release by these cells, while increasing their excitability, events that are dependent on mTORC2 activity (Mazei-Robison et al., 2011) . Activation of the mTOR pathway in the CA3 hippocampal region is necessary for the acquisition of morphine CPP in rats (Cui et al., 2010) . Moreover, systemic inhibition of mTOR with rapamycin after reexposure to a morphine paired compartment inhibits CPP in a dose dependent fashion, an effect that was replicated with cocaine and alcohol (Lin et al., 2014) . Hence, mTOR may play a role in the reconsolidation of drug paired memories. Elsewhere, a single dose of rapamycin was able to reduce the craving elicited by drug related cues in human heroin addicts (Shi et al., 2009 ).
To date, we are unaware of any study that has used a self-administration protocol to study the effects of opioids on the mTOR signaling pathway in rodents. Here, we assessed the effects of morphine self-administration, followed by extinction training, on the mTOR pathway in male Lewis rats. For this purpose, we chose three brain areas known for their involvement in opioid reinforcement and extinction learning: the amygdala, the NAcc, and the prefrontal cortex (PFC). The expression of several mediators of the mTOR pathway was analyzed using RT-qPCR and we also assessed the levels of some of their phosphorylation sites required for their activation in western blots.
-Methods

-Animals
Adult male Lewis rats (Charles River Laboratories) were housed in groups of 4 in a temperature and humidity controlled facility, and on a 12h/12h light/dark cycle (lights on at 8:00am) with ad libitum access to food (standard commercial rodent diet A04/A03: Panlab) and water. Animals were allowed at least one week to acclimatize to the animal facility and they weighed around 250-300 g when the experimental procedures commenced. All the animals were maintained and handled according to European Union guidelines for the care of laboratory animals (EU Directive 2010/63/EU governing animal experimentation).
-Apparatus
Twelve operant conditioning chambers (Coulborne Instruments), each equipped with a pellet dispenser and a microliter injection pump, were used to assess operant food rewarded behavior, and for the morphine self-administration and extinction studies. A catheter was connected to the rats and held in place with a spring-tether system, and a rotating swivel, which allowed the animals to move freely inside the chamber. Two levers were available throughout all the sessions, one of them inactive.
-Experimental protocol
-Lever press instrumental training
At the beginning of the experiment, all the rats received daily instrumental training sessions with food pellets as reinforcers (grain-based rodent tablet, Testdiet™) on a fixed ratio 1 schedule, facilitating the acquisition of self-administration behavior. The sessions lasted 30 minutes and continued until the animals developed a robust lever press behavior (at least 100 lever presses in three consecutive training sessions).
-Surgery
Rats were anesthetized with an isoflurane/oxygen mixture, and a catheter was inserted into the right jugular vein of the animal and secured there with silk thread knots. The catheter was fixed subcutaneously around the neck, exiting the skin at the midscapular region. A pedestal of dental cement was then mounted on the skull of the rat in order to attach the tethering system. After surgery, the rats were allowed to recover for 7 days and a NSAID (meloxicam -Metacam™: 15 drops of a 1.5 g/ml solution per 500 ml of water) was added to the drinking water. Until the end of the self-administration procedure, the catheters were flushed daily with a sterile saline solution containing sodium heparin (100 IU/ml) and gentamicin (1mg/ml) to maintain catheter patency and to prevent infections.
-Morphine self-administration
A week after recovery from surgery, the rats underwent 19 daily sessions of morphine selfadministration. During the dark phase of the light cycle, for 12 hours rats were allowed daily access to morphine (1 mg/kg in a sterile saline -0.9% NaCl-solution) or its vehicle alone under a fixedratio 1 reinforced schedule. During these sessions, one active lever press resulted in morphine infusion (1 mg/kg morphine in saline solution delivered over 10 seconds) followed by a 10 second time-out. A light cue located above the lever indicated the availability of the drug and a limit of 50 infusions per session was set in order to avoid overdosing. One day after the last session, two groups of rats were sacrificed (Vehicle self-administration -VhSA, n=10; Morphine selfadministration -MSA, n=10), and their brains were processed and stored.
-Extinction training
The remaining rats were given 15 daily sessions of extinction training using the same selfadministration protocol, although in this phase all the rats received a saline solution instead of morphine. One day after the last extinction session, the two remaining groups of rats (Vehicle extinction -VhEx, n=8; Morphine extinction -MEx, n=8) were sacrificed, and their brains processed and stored. 
-Sample processing
On the day of the sacrifice, the rats were decapitated and the amygdala (mainly the basolateral amygdala -BLA), NAcc (both shell and core) and PFC (mostly the orbitofrontal cortex, OFC) were dissected from the brains using a brain matrix (see Fig. 2 ). All the surfaces and tools used for dissection were sterilized and treated with RNAseZap® (Ambion™), and all the steps were carried out with caution to maintain RNA integrity. The tissue samples from one hemisphere (randomized) were preserved overnight at 4 ºC in RNAlater® (Ambion™) and then stored at -70 ºC in RNAlater® for later RT-qPCR analysis. The samples of the other hemisphere were snap frozen with dry ice and stored at -70º for western blot analysis. 
-RT-qPCR analysis
The samples stored in RNAlater® were homogenized in QIAzol lysis reagent (QIAgen) using a pellet pestle. The total RNA was extracted and precipitated using the chloroform, isopropanol and ethanol method (Chomczynski and Sacchi, 1987) with glycogen as a carrier. The precipitate was dissolved in RNAse free water, and the concentration and RNA integrity was assessed in a bioanalyzer (Agilent 2100). The RNA concentration in each sample was adjusted by adding RNAse free water and to avoid genomic DNA contamination, DNAse digestion was performed (DNAse I, Amplification Grade, Invitrogen) following the manufacturer's instructions. Finally, the samples were retrotranscribed using a commercial kit (Biorad iScript™ cDNA Synthesis Kit). PCR assays were performed on a real time PCR detection system (CFX9600, Biorad) with a SSO Advanced SYBR mix (Biorad) using the primers indicated in the supplementary materials section. The raw data was normalized using the ΔΔCt method (Livak and Schmittgen, 2001 ) using Gapdh as a reference gene and the reaction efficiencies were obtained using LinRegPCR software (Ruijter et al., 2009 ).
-Western blotting
The tissue samples were homogenized using a pellet pestle in 10 volumes of lysis buffer: 50mM HEPES [pH7.5], 320 mM sucrose, (Complete TM EDTA-free, Roche) protease inhibitors, and phosphatase inhibitors (PHOStop TM , Roche). The resulting homogenate was centrifuged at 2000 g and at 4 ºC for 10 minutes, the supernatants were recovered and their protein concentration was assessed using the Bradford assay (Bio-Rad Protein Assay). The protein extracts (3 mg) were mixed with 6X Laemmli buffer and loaded onto 8% SDS-PAGE gels, resolved by electrophoresis and transferred to PVDF membranes. After blocking non-specific interactions with 5% BSA for one hour, the membranes were probed overnight with the primary antibodies (see supplementary materials) that were then recognized with a horseradish peroxidase-conjugated secondary antibody (see supplementary materials). Antibody binding was visualized by chemiluminescence (ECL Plus Western Blotting Substrate, Pierce™). As a control for protein loading, we measured the total protein loaded by adding 2,2,2-trichloroethanol to the gels prior to polymerization (final concentration 0.5% v/v: Ladner et al., 2004) , and after resolving the gel, it was excited with an UV transilluminator and the fluorescence emitted was measured. We used a CCD based detector (Amersham Imager 600) to capture both the chemiluminiscence and the UV/fluorescence images, and the ImageJ software to analyze and quantify them. When necessary, antibodies were stripped using a harsh stripping protocol ("Stripping for reprobing": Abcam®).
-Statistical analysis
The data obtained from the behavioral experiments were analyzed using repeated measures ANOVA. The analysis of the self-administration data had Sessions as a within-subject factor, and Treatment (M or Vh) and Phase (SA or Ex) as the between-subject factors. To analyze the extinction behavioral data, only Treatment was used as the between-subject factor. The degrees of freedom were adjusted when the sphericity assumption was violated by applying the GreenhouseGeisser correction.
To analyze the biochemical assays we performed two-way ANOVAs with two betweensubject factors: Treatment and Phase. When the required assumptions for ANOVA were not met, we used a Kruskal-Wallis test followed by a multiple comparison of groups, based on the descriptions given by Conover (Conover, 1999) .
Finally, we analyzed the potential correlations between the behavioral and biochemical variables, for which we selected the following dependent behavioral variables: cumulative consumption in the morphine self-administration sessions (TotSA), cumulative consumption in the last 5 morphine self-administration sessions (Last5SA), cumulative consumption during the first 3 extinction sessions (First3Ex); and the linear regression slope of the consumption during the first 3 extinction sessions (Slope3EX). We chose the first 3 extinction sessions because the number of lever presses of the group MEx from the third session was already similar to the VhEx group. We then measured the relationship between these variables and the biochemical variables using Pearson's r, Spearman's ρ and Kendall's τ as the correlation coefficients. Given the heterogeneity of the distributions and the number of correlations studied, we only report those that were significant when assessed by the three methods indicated.
-Software
All the statistical analyses were performed using SPSS 24 (IBM) and the level of significance was set to α=0.05. The Kruwal 10.3 software was used for the non-parametric multiple comparison of groups. All the graphs were designed using the PRISM 6 software (GraphPad Software, Inc).
-Results
-Behavioral data
All the experimental animals achieved a high number of lever presses during the acquisition phase, probably due to the previous autoshaping training (Fig. 1) . Subsequently, the rats that received saline lowered the rate of lever pressing, whereas the number of lever presses of the rats that received morphine remained high. During the first extinction session, there was a surge in the number of lever presses in the rats of the MEx group, although this decreased gradually in the following sessions until it reached values similar to those of the VhEx group. When we performed the Mauchly's test for sphericity, the self-administration data did not meet the assumption of sphericity (χ 2 170 =343.11, p<0.001) and therefore, the degrees of freedom were corrected using a Greenhouse-Geisser transformation (ε=0.45). The two way-repeated measures mixed ANOVA showed a significant effect of the Sessions factor (F 8.03,248.89 =4.23, p<0 .001, η G ²=0.05) and an almost significant Treatment x Sessions interaction (F 8.029,248.891 =1.948, p=0.053, η G ²=0.024). Given that the Greenhouse-Geisser transformation employed is particularly conservative and considering the lever presses profile observed (see Fig. 1 ), the lever presses during the sessions are likely to be different for the MSA and VhSA groups. Indeed, when we assessed the overall average values of all the self-administration sessions we found a significant effect of the Treatment factor (F 1,31 =45,07, p<0.001, η 2 =0.98). We did not find any significant Treatment*Phase interaction (F 1,31 =10,43, p>0.05) or any effect of the Phase factor (F 1,31 =84,63, p>0.05). Therefore, it was concluded that the groups that underwent extinction performed similarly to their counterparts during the self-administration procedure. Regarding the extinction session data, the assumption of sphericity was also violated (χ 2 104 =198.23, p<0.001) and a Greenhouse-Geisser correction had to be applied again (ε=0.26). Similarly, we found a significant effect of the Sessions factor (F 3.64,51.02 =9.76, p<0.001, η G ²=0.35) and a significant Treatment x Session interaction (F 3.64,51.02 =4.12, p<0.01, η G ²=0.18), showing that both experimental groups performed differently across the sessions. We also found a significant effect of the Treatment factor (F 1,14 =10.99, p<0.01, η 2 =0.92) for the average values throughout the extinction sessions (see Fig. 1 ). To test whether the rats in the MEx group had extinguished the morphine self-administration behavior, we compared the mean number of lever presses during the last three days of extinction in the MEx and VhEx groups. Importantly, no significant differences were observed between these groups of rats (t 14 =-1.41, p>0.05).
-Gene expression
In the amygdala, the gene expression analysis identified a significant effect of the treatment on the expression of the Regulatory Associated Protein of MTOR Complex 1 (Rptor) (F 1,28 =5.57, p<0.05, η 2 =0.16) and the Eukaryotic Translation Initiation Factor 4E Binding Protein 2 (Eif4ebp2) (F 1,28 =4.28, p<0.05, η 2 =0.13: Table 1 ). The expression of these genes increased in the rats that self-administered morphine and this effect persisted even after extinction training. In this structure, we also found a main effect of the Phase factor on the expression of AKT Serine/Threonine Kinase 1 (Akt1 effect appeared not to be significant. There were no statistically significant differences in the expression of any of the genes analyzed in the NAcc.
-Phosphoprotein levels
We did not find any significant effects of the Treatment on the phosphoproteins assessed in each of the brain areas examined. However, in the amygdala the Phase factor affected the levels of phospho-GSK-3α (Ser21/9) (F 1,28 =5.32, p<0.05, η 2 =0.14) and the 68kDa band of phospho-PDK1 (Ser241) (F 1,29 =6.18, p<0.05, η 2 =0.17). The levels of both these phosphoproteins were lower after the extinction sessions (Fig. 3,4 and 5). 
-Correlations
In the MSA group (Fig. 6) , the TotSA was correlated with the expression of the Eukaryotic Translation Elongation Factor 1 Alpha 1 (Eef1a1) in the amygdala (r=0.86, p<0.01; ρ=0.79, p<0.05; τ=0.571; p<0.05). Likewise, in these rats the Last5SA was correlated with the expression of Eef1a1 (r=0.77, p<0.05; ρ=0.81, p<0.05; τ=0,64, p<0.05) and the Serum/Glucocorticoid Regulated Kinase 1 (Sgk1) (r=0.76, p<0.05; ρ=0.71, p<0.05; τ=0.571, p<0.05) in the amygdala. In the MEx group (Fig. 7) , we found that Mtor expression in the amygdala was significantly correlated to Last5SA (r=0.82, p<0.05; ρ=0.88, p<0.01; τ=0.79, p<0.01) and that Glycogen Synthase Kinase 3 Alpha (Gsk3a) mRNA expression in the amygdala was correlated to the First3Ex (r=0.79, p<0.05; ρ=0.71, p<0.05; τ=0.76, p<0.01). Similarly, there was also a significant inverse correlation between both the upper (r=-0.92, p<0.01; ρ=-0.75, p<0.05; τ=-0.62, p<0.05) and lower (r=0.81, p<0.05; ρ=0.8, p<0.05; τ=-0.69, p<0.05) phPDK1 (Ser241) bands in the PFC and Slope3Ex. We assessed the effects of morphine self-administration and the subsequent extinction of this behavior on the expression of several genes and on the levels of some phosphorylated proteins of the mTOR signaling pathway in three brain areas related to reward learning and extinction: the amygdala, the NAcc and the prefrontal cortex. The morphine self-administration program employed only affected the expression of the Rptor and Eif4ebp2 genes in the amygdala, an effect that persisted after extinction (Table 1 ). The Rptor gene encodes the regulatoryassociated protein of mTOR (Raptor), a protein in the mTOR complex 1 (mTORC1), while the product of the Eif4ebp2 gene is the eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2), one of the downstream effectors of this complex (Shimobayashi and Hall, 2014) . Raptor regulates mTOR kinase activity, and it also recruits mTORC1 substrates like the S6 kinases and EIF4E binding proteins like EIF4EBP2 (Hara et al., 2002; Kim and Sabatini, 2004; Ma and Blenis, 2009 ). The eIF4EBP proteins in turn regulate EIF4E activity, which is responsible for the cap-dependent translation of mRNAs (Richter and Sonenberg, 2005) . Our dissection of the amygdala mostly included the BLA, an area with an important role in conditioning learning given that it encodes the motivational value of the conditioned stimulus, either appetitive or aversive (Everitt et al., 2003) . The BLA also has a role in the formation, retrieval and reconsolidation of drug-related memories (Luo et al., 2013) . Indeed, c-Fos activity in the BLA is enhanced in rats showing CPP or conditioned place aversion (CPA) to morphine (Guo et al., 2008) . Considering all this evidence together, the enduring increase in mTORC1 activity after morphine selfadministration in the BLA (as suggested by the elevated transcription of the Rptor and Eif4ebp2 genes) could contribute to the stabilization of those morphine-related aversive and appetitive memories that persist even after extinction.
Another interesting result was the variation in Insr gene expression that decreases drastically after morphine self-administration relative to rats exposed to the vehicle alone (Table 1) . The Insr gene encodes the insulin receptor, one of the upstream activators of the PI3K/Akt/mTOR pathway (Niswender et al., 2003; Taha and Klip, 1999) . Moreover, morphine can also activate this pathway through µ opioid receptors (Law et al., 2000; Polakiewicz et al., 1998) . It is plausible that our results could reflect the opioid inhibition of insulin signaling due to a crosstalk between the downstream signaling pathways of both receptors, as shown previously in cell cultures (Li et al., 2003) . These results are also consistent with the evidence that a chronic morphine regime downregulates the insulin receptor substrate 2 (IRS2)-Akt signaling pathway in the ventral tegmental area (Russo et al., 2007) . This dampened endogenous insulin signaling might contribute to the development or expression of morphine withdrawal syndrome. Indeed, insulin administration reduces withdrawal symptoms in rats (Singh et al., 2015) . Furthermore, rats that self-administered morphine did not display the decrease over time that vehicle treated rats did. This increase in the Insr might suggest recovery from withdrawal syndrome although direct evidence for this is lacking.
We also found some changes independent of the treatment but that rather reflected the experimental phase. The Akt1 and Igfr2 genes were more strongly expressed in the amygdala in the groups that underwent extinction training, even in the rats that received a saline solution during the self-administration phase. As opposed to the amygdala, Igfr2 expression in the PFC was reduced in both groups after extinction (Table 1) . These changes could reflect the natural regulation of these genes over the lifetime of the rats or maybe, they were a result of the experimental manipulations the rats were subjected to (surgery, handling, behavioral experiments…). Apart from the changes in gene expression, we also found variations in the phosphorylation of GSK-3α (Ser21/9) and of the 68kDa isoform of PDK1 (Ser241), both of which changed after extinction in the two groups irrespective of their prior treatment (Fig. 5) . The levels of both phosphoproteins decreased in the BLA after extinction, and those of phospho-GSK-3α (Ser21/9) also tended to fall in the NAcc (Fig. 4) .
Although most of the variables measured did not differ significantly between the experimental groups, some were correlated with behavioral variables and this leads to some interesting interpretations. For example, the Eef1a1 mRNA transcripts in the amygdala of the MSA rats were positively correlated with overall morphine consumption, and with its consumption during the last 5 days of self-administration (Fig. 4) . The Eef1a1 gene encodes the Elongation factor 1-alpha 1 protein (eEF1a1). This protein is responsible for the enzymatic delivery of all aminoacyltRNAs to the ribosome, permitting the elongation of growing peptides and making it a key element integrating the cellular pathways regulating protein synthesis (Mateyak and Kinzy, 2010) . Eef1a translation is supposed to be regulated by S6 phosphorylation by p70S6k, a mTORC1 target (Jefferies et al., 1994; Kimball et al., 1999) . These findings, together with the long-lasting increased amygdalar expression of the Rptor and eif4ebp2 genes in morphine-exposed animals, suggest that this opiate activates the translational machinery in the amygdala. As suggested previously, such an effect could be indicative of the engagement of plasticity-related process in a similar way to those invoked by long-term potentiation (Tsokas et al., 2005) . We also found a positive correlation between the amygdalar Sgk1 mRNA levels (serum and glucocorticoid-induced protein kinase 1) and morphine consumption during the last 5 days of self-administration (Fig. 4) . Moreover, SGK1 mRNA expression was increased after morphine self-administration in all of the brain areas studied, although these changes didn´t reach statistical significance (Table 1) . SGK1 is a serine/threonine kinase that is activated by the phosphorylation of a hydrophobic motif at Ser 422 , a phenomenon mediated by the mTORC2 complex (García-Martínez and Alessi, 2008) . Although we do not detect changes in proteins associated to the mTORC2 complex, such as Rictor, this correlation suggests the activity of this complex may be modulated by morphine consumption. To our knowledge, this is the first study showing the potential modulation of Sgk1 by opiates in the amygdala, although other groups studying other brain areas have documented a similar effect. For example, Sgk1 mRNA expression was enhanced in whole brain lysates after chronic oxycodone administration, a µ opioid receptor agonist (Hassan et al., 2009) . Elsewhere, Sgk1 mRNA levels and activity was seen to increase in the VTA after 7 days of passive morphine administration (i.p. 15mg/kg: Heller et al., 2015) and chronic morphine administration passively increases mTORC1 activity in the VTA, while decreasing that of mTORC2. Such treatment also decreased the soma size of VTA dopaminergic neurons, an effect that increased cell activity but that decreased dopamine output in the NAcc shell. These effects were blocked by overexpressing Rictor in the VTA, indicating that reduced mTORC2 activity mediates these adaptations (Mazei-Robison et al., 2011) . SGK1 has previously been shown to play an important role in spatial memory consolidation (Lee et al., 2006; Tsai et al., 2002) and LTP (Ma, 2006) , and in the light of these results, this kinase may also be important in the effects of opioids in the brain as well.
We also found a correlation between Mtor expression in the amygdala and the consumption of morphine during the last five days of self-administration, yet only in the MEx rats (Fig. 5) . The BLA is known to participate in the memory consolidation processes underlying extinction, as evident in cocaine extinction (Fuchs et al., 2002) , extinction of fear (Falls et al., 1992; Lu et al., 2001 ) and extinction of amphetamine CPP (Schroeder and Packard, 2004) . The fact that we found this correlation only after extinction training could mean that Mtor expression in the amygdala has a role in the consolidation of extinction memory. Indeed, the inhibition of mTORC1 by rapamycin was recently shown to attenuate the consolidation of extinction memories associated to an auditory threat. Moreover, an effector of mTOR, S6K1, was activated in the BLA during extinction, although apparently this activation was mediated by ERK (Huynh et al., 2017) .
There was another correlation between gene expression in the amygdala and a behavioral variable in the extinction group, with Gsk3α expression being related to the number of lever presses during the first three days of extinction (Fig. 5) . Self-administration extinction occurs during these three first days, such that this result could reflect a slower extinction rate in the animals that expressed more Gsk3α in the amygdala. GSK3β activity in the BLA is stronger after exposure to drug associated cues. Moreover, intraBLA injections of SB216763, a non-selective GSK3 inhibitor, immediately after the reactivation of cocaine cue memory impairs the preference of rats for the drug context cue, revealing a role for GSK3 in the persistence of the incentive value associated to drug associated cues . This effect was replicated in mice using i.p. SB216763 (Shi et al., 2014) . Since SB216763 has a similar K i s for GSK3α and GSK3β (Coghlan et al., 2000) , it is tempting to speculate that these effects could be mediated by either or both the GSK3 isoforms. Whether or not one of these isoforms in particular is responsible for the resistance to extinction of the response to drug associated cues, the administration of GSK3 inhibitors during withdrawal would seem to be an interesting approach for the treatment of addictions.
The only correlation involving a biochemical variable outside of the BLA was the inverse relationship between the amount of phPDK1 (Ser241) in the PFC and the slope of the regression line of morphine consumption during the first three days of extinction (Fig. 5) . This behavioral variable can be considered an estimate of the extinction rate of the rats, indicating that the rats with more phPDK1 (Ser241) in the PFC extinguished faster. These results are coherent with the known activity of PDK1 and also, with the territories of the PFC dissected in our study. Indeed, PDK1 activity is required for Akt (Sarbassov et al., 2005) , p70S6k (Pullen et al., 1998) and SGK1 activation (García-Martínez and Alessi, 2008) , all part of the mTOR pathway and important regulators of protein synthesis. Alternatively, the PFC samples taken by us mostly contain the orbitofrontal cortex (OFC), a critical area signaling information about specific outcomes (Schoenbaum and Esber, 2010) . Moreover, lesions or inactivation of the OFC impaired extinction of a reinforced response in rats (Joel and Klavir, 2006; Panayi and Killcross, 2014) and macaque monkeys (Butter, 1969; Izquierdo and Murray, 2005) . In humans, extinction learning is also mediated by the OFC, as seen in a study using functional magnetic resonance imaging (Gottfried and Dolan, 2004) .
-Concluding remarks
In this study, we have addressed the putative effects of morphine self-administration and extinction on several elements of the mTOR pathway. Of the three areas studied, the most significant results were found in the amygdala. The role of this area in the processes of drug addiction and relapse is well known but to our knowledge, no one has previously observed the potential involvement of the mTOR pathway in this limbic structure. The genes and phosphoproteins identified are mainly involved in regulating protein synthesis, and they may also be recruited during memory formation and reconsolidation, concurring with earlier data. In the light of these findings, it would be interesting to more directly study the therapeutic value of this signaling pathway in opioid-related disorders.
